AXIM® Biotechnologies to Present at Cannastocks 2019 Q1 Conference

NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech”, “Axim”, or the “Company”), a world leader in cannabinoid research and development, today announced that the Company will be attending and presenting at Cannastocks 2019 Q1 Conference, taking place in New York on May 15, 2019.